Literature DB >> 22969936

Increased expression of the prolactin receptor is associated with malignant laryngeal tumors.

Luis R González-Lucano1, José F Muñoz-Valle, Rafael Ascencio-Cedillo, José A Domínguez-Rosales, Gonzalo López-Rincón, Susana Del Toro-Arreola, Miriam Bueno-Topete, Adrián Daneri-Navarro, Ciro Estrada-Chávez, Ana L Pereira-Suárez.   

Abstract

The altered expression of the prolactin receptor (PRLR) has been associated with the development of various types of cancer, particularly breast, prostate and endometrial cancer. However, in laryngeal tumors, the expression of PRLR has not yet been documented. The aim of this study was to determine the expression and localization of PRLR in laryngeal cancer (LC) in comparison with recurrent respiratory papillomatosis (RRP). PRLR expression was analyzed in 48 paraffin-embedded tissues (18 RRP and 30 laryngeal cancer tissues) by immunoperoxidase staining. Furthermore, PRLR expression was evaluated in ten samples from each group by Western blot analysis and quantitative real-time PCR. PRLR was observed in all laryngeal tumors at different intensities. PRLR overexpression was significantly associated (P<0.005) with LC. The staining pattern was homogeneous, mainly cytoplasmic, and confined to the tumor area. We found increased expression of different isoforms in LC in comparison with RRP. Our results suggest a possible role of PRL/PRLR in the development of LC. PRLR may be useful as a target for further investigations in laryngeal tissues.

Entities:  

Year:  2012        PMID: 22969936      PMCID: PMC3438611          DOI: 10.3892/etm.2012.464

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  29 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Clinicopathological significance of prolactin receptor expression in colorectal carcinoma and corresponding metastases.

Authors:  Lars Harbaum; Marion J Pollheimer; Thomas Bauernhofer; Peter Kornprat; Richard A Lindtner; Andrea Schlemmer; Peter Rehak; Cord Langner
Journal:  Mod Pathol       Date:  2010-05-07       Impact factor: 7.842

3.  Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells.

Authors:  R Das; B K Vonderhaar
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Stabilization of prolactin receptor in breast cancer cells.

Authors:  Y Li; C V Clevenger; N Minkovsky; K G S Kumar; P N Raghunath; J E Tomaszewski; V S Spiegelman; S Y Fuchs
Journal:  Oncogene       Date:  2006-03-23       Impact factor: 9.867

Review 5.  Impact of prolactin receptor isoforms on reproduction.

Authors:  Nadine Binart; Anne Bachelot; Justine Bouilly
Journal:  Trends Endocrinol Metab       Date:  2010-02-09       Impact factor: 12.015

6.  Molecular identification of 7 human papillomavirus types in recurrent respiratory papillomatosis.

Authors:  M Peñaloza-Plascencia; H Montoya-Fuentes; S E Flores-Martínez; F J Fierro-Velasco; J M Peñaloza-González; J Sánchez-Corona
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2000-09

7.  Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR.

Authors:  S K Peirce; W Y Chen; W Y Chen
Journal:  J Endocrinol       Date:  2001-10       Impact factor: 4.286

8.  Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions.

Authors:  I Leav; F B Merk; K F Lee; M Loda; M Mandoki; J E McNeal; S M Ho
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

Review 9.  Prolactin and breast cancer risk.

Authors:  Shelley S Tworoger; Susan E Hankinson
Journal:  Cancer Lett       Date:  2006-03-10       Impact factor: 8.679

10.  Oncogene-mediated inhibition of glycogen synthase kinase 3 beta impairs degradation of prolactin receptor.

Authors:  Alexander Plotnikov; Ying Li; Thai H Tran; Weigang Tang; Juan P Palazzo; Hallgeir Rui; Serge Y Fuchs
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

View more
  3 in total

1.  Prolactin and prolactin receptor expression in cervical intraepithelial neoplasia and cancer.

Authors:  Rafael Ascencio-Cedillo; Edgar Ivan López-Pulido; José Francisco Muñoz-Valle; Nicolás Villegas-Sepúlveda; Susana Del Toro-Arreola; Ciro Estrada-Chávez; Adrian Daneri-Navarro; Ramón Franco-Topete; Delia Pérez-Montiel; Alejandro García-Carrancá; Ana Laura Pereira-Suárez
Journal:  Pathol Oncol Res       Date:  2014-07-03       Impact factor: 3.201

2.  Prolactin and cancer: Has the orphan finally found a home?

Authors:  Bipin Kumar Sethi; G V Chanukya; V Sri Nagesh
Journal:  Indian J Endocrinol Metab       Date:  2012-12

3.  STAT3 activation is required for the antiapoptotic effects of prolactin in cervical cancer cells.

Authors:  Adrián Ramírez de Arellano; Edgar I Lopez-Pulido; Priscila A Martínez-Neri; Ciro Estrada Chávez; Renee González Lucano; Mary Fafutis-Morris; A Aguilar-Lemarroy; José F Muñoz-Valle; Ana Laura Pereira-Suárez
Journal:  Cancer Cell Int       Date:  2015-09-04       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.